Atlas Venture Life Science Advisors, LLC Portfolio Holdings

Atlas Venture Life Science Advisors, LLC

  • $810 Million
  • Q3 2024

Atlas Venture Life Science Advisors, LLC has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $810 Million distributed in 14 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Dyne Therapeutics, Inc. with a value of $288M, Kymera Therapeutics, Inc. with a value of $232M, Third Harmonic Bio, Inc. with a value of $148M, Day One Biopharmaceuticals, Inc. with a value of $89.6M, and Generation Bio Co. with a value of $20.5M.

Examining the 13F form we can see an increase of $59.8M in the current position value, from $751M to 810M.

Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $810 Million
Healthcare: $810 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 14
  • Current Value $810 Million
  • Prior Value $751 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email